EdgarLookup

Citius Pharmaceuticals, Inc. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Annual Quarterly Insiders
Insider Title Type Shares Price Value Owns After Date
Holuka Eugene Myron Tax Withholding 48 $0.75 $36 2,367 Mar 13, 2024
Webb Carol Tax Withholding 236 $0.77 $182 11,835 Mar 4, 2024
HOLUBIAK MYRON Z President and CEO Purchase 558,597 $0.90 $502,737 1,992,243 Sep 27, 2019
Mazur Leonard L Executive Chairman Purchase 2,234,700 $0.90 $2,011,230 10,255,343 Sep 27, 2019
HOLUBIAK MYRON Z President and CEO Purchase 129,450 $1.55 $200,648 1,433,646 Apr 3, 2019
Mazur Leonard L Executive Chairman Purchase 1,165,048 $1.55 $1,805,824 8,020,643 Apr 3, 2019
HOLUBIAK MYRON Z President and CEO Purchase 784,314 $1.28 $1,003,922 1,304,196 Aug 13, 2018
Mazur Leonard L Executive Chairman Purchase 3,137,255 $1.28 $4,015,686 6,855,595 Aug 13, 2018
Mazur Leonard L Executive Chairman Purchase 167,504 $2.99 $500,837 3,718,340 Mar 29, 2018
HOLUBIAK MYRON Z President and CEO Purchase 2,915 $3.09 $9,007 519,882 Mar 28, 2018
Mazur Leonard L Executive Chairman Purchase 213,106 $4.69 $999,467 3,550,836 Dec 19, 2017
Mazur Leonard L Executive Chairman Purchase 11,000 $2.68 $29,480 3,337,730 Aug 24, 2017
Mazur Leonard L Executive Chairman C 1,547,067 $3.09 $4,780,437 3,326,730 Aug 8, 2017
HOLUBIAK MYRON Z President and CEO Other 7,754,497 7,754,497 Mar 30, 2016
Mazur Leonard L Purchase 5,000,000 $0.60 $3,000,000 5,457,143 Mar 30, 2016